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5. Zusammenfassung 
Die Verfügbarkeit von Nährstoffen ist grundlegend für das Gleichgewicht zwischen 
Anabolismus und Katabolismus in Säugetierzellen. Im momentanen Verständniß der 
Zellbiologie führt ein Mangel von extrazellulären Nährstoffen zur Makroautophagie. Dies ist 
ein vorrangig katabolischer Prozess, bei dem Nährstoffe aus dem Abbau zellulärer 
Bestandteile gewonnen werden, um so das Überleben der Zelle zu sichern. In der hier 
vorliegenden Arbeit habe ich herausgefunden, dass β-Zellen des Pankreas, welche eine 
Schlüsselfunktion im Stoffwechsel von Säugetieren übernehmen, einen anderen und bisher 
unbekannten Mechanismus aufzeigen, um sich einem Mangel an Nährstoffen anzupassen. Bei 
einem Entzug von Nährstoffen, werden in β-Zellen reifende Insulin-haltige Granula abgebaut, 
indem sie mit Lysosomen in der Nähe des Golgi-Apparates fusionieren. Diesen Prozess werde 
ich im Verlauf als „Starvation-Induced Nascent Granule Degradation“ (SINGD) bezeichnen. 
Der zelluläre Sensor für Nährstoffe, mTORC1, bindet dann die Lysosomen, wodurch er lokal 
aktiviert wird und somit die Makroautophagie inhibiert. Zudem zeige ich, dass SINGD von 
der Protein Kinase D1 (PKD1), einem wichtiger Regulator der Insulin-Granula Bildung am 
Trans-Golgi-Netzwerk, reguliert wird. Die Aktvierung von SINGD bei Nährstoffmangel wird 
durch eine schnelle Inaktivierung von PKD1 am Trans-Golgi Netzwerk ausgelöst. Das zeigt, 
dass sich ß-Zellen im Gegensatz zu den meisten anderen Zelltypen nicht mit Hilfe der 
Makroautophagie an Nährstoffmangel anpassen, sondern die Funktion des Golgi 
modifizieren.  
Viele Stoffwechselprodukte die bei einer Makroautophagie gebildet werden, verstärken die 
Freisetzung von Insulin. Daher würde eine verstärkte Makroautophagie in ß-Zellen die 
normale Reduktion der Insulin-Freisetzung bei Hunger stören. Tatsächlich führt eine 
Zusammenfassung 
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induzierte Makroautophagie in ß-Zellen auch zu einer erhöhten Insulin Freisetzung trotz 
Nähstoffmangel. Da ß-Zellen aber vorrangig neugebildete Granula freisetzen, kann SINGD 
wahrscheinlich das Ausschütten von Insulin begrenzen und verhindert neben der 
Makroautophagie auch den stimulierenden Effekt durch die neu gebildeten 
Stoffwechselprodukte.  Damit ermöglicht die SINGD-vermittelte Inhibition der 
Makroautophagie die verminderte Insulin Freisetzung bei Nährstoffmangel. 
Zusammengefasst beschreibt der hier entdeckte Mechanismus eine wichtige evolutionäre 
Anpassung eines spezialisierten sekretorischen Zelltyps der auch in anderen sekretorischen 
Zellen von Bedeutung sein könnte. Da die Autophagie in ß-Zellen eine wichtige Rolle bei 
Diabetes spielt, bietet meine Arbeit auch für das Verständnis dieser Krankheit neue und 
interessante Perspektiven. 
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6. Summary 
Nutrient availability is the major factor determining the balance between anabolic and 
catabolic reactions in mammalian cells. According to a prevailing concept in cell biology, a 
shortage of external nutrients results in induction of macroautophagy, a predominant catabolic 
pathway that supplies metabolites needed for the cell survival through degradation of cellular 
components. In this study, I have found that pancreatic β cells, key regulators of systemic 
metabolism in mammals, employ a very distinct and so far unknown mechanism to adapt to 
nutrient depletion. Starvation of β cells induces selective degradation of nascent insulin 
secretory granules through their fusion with lysosomes in the Golgi area, a process I will term 
Starvation-Induced Nascent Granule Degradation (SINGD). The nutrient sensor mTORC1 is 
recruited to these lysosomes, which leads to its local activation and immediate suppression of 
macroautophagy upon starvation. Furthermore, I have found that Protein Kinase D1 (PKD1), 
a major regulator of insulin granule biogenesis at the Trans-Golgi-Network, controls SINGD. 
Nutrient deprivation leads to a rapid inactivation of PKD1 at the Trans-Golgi-Network, which 
in turn triggers SINGD. Therefore, macroautophagy is not the strategy of choice in β cells to 
adapt to nutrient depletion as seen for most other cell types. Instead, the nutrient starvation 
response is directly linked to Golgi function. 
Several metabolites generated through macroautophagy are known to trigger insulin release. 
Thus, increased macroautophagy in β cells may interfere with fasting-induced suppression of 
insulin secretion. Indeed, increasing macroautophagy in β cells during starvation enhances 
insulin secretion. In addition, as β cells preferentially secrete nascent secretory granules, 
SINGD is likely to limit insulin release, thus compensating stimulatory effects of generated 
metabolites on the secretion of insulin. Therefore, SINGD-mediated suppression of 
macroautophagy contributes to fasting-induced suppression of insulin secretion. 
Summary 
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Conclusively, the identified mechanism constitutes an important evolutionary adaption in a 
specialized secretory cell type that could also be important in other secretory cells. Given the 
important role of autophagy in β cells in the context of diabetes, my study may also offer 
interesting perspectives in the diabetes field. 
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7. Introduction 
7.1. Mammalian cells sense nutrients to regulate metabolism 
The availability of nutrients determines the metabolic activity of cells and organisms. 
Therefore, proper nutrient sensing is crucial for cell functioning. Mammalian cells sense 
nutrients on both local (cellular) and systemic (organismal) levels. On the cellular level the 
cells receive nutrients in the form of glucose, amino acids and other metabolites, while the 
nutrient status of the organism  is translated to the cells through the whole plethora of secreted 
factors, such as hormones produced by endocrine system. In mammalian cells, several 
signalling networks collect inputs from nutrients to control catabolic and anabolic pathways 
(Howell, Ricoult et al. 2013; Yuan, Xiong et al. 2013).  
One of the best studied cellular nutrient sensors is the multiprotein mammalian (or 
mechanistic) Target Of Rapamycin Complex 1 (mTORC1). In presence of nutrients, 
mTORC1 promotes anabolism through upregulation of protein translation, biosynthesis of 
lipids and nucleic acids (Wullschleger, Loewith et al. 2006; Laplante and Sabatini 2012; 
Howell, Ricoult et al. 2013). In particular, mTORC1 promotes lipogenesis through the 
activation of transcription factor Sterol Regulatory Element Binding Protein (SREBP) via 
several mechanisms, including inhibition of the phosphatase Lipin1 and activation of the 
ribosomal S6 Kinase (S6K) (Porstmann, Santos et al. 2008; Duvel, Yecies et al. 2010; Lewis, 
Griffiths et al. 2011; Peterson, Sengupta et al. 2011; Owen, Zhang et al. 2012).The 
biosynthesis of nucleic acids (DNA and RNA) is enhanced by mTORC1 through the S6K-
dependent phosphorylation of Carbamoyl-phosphate synthetase 2, Aspartate 
transcarbamoylase, and Dihydroorotase (CAD) and SREBP-dependent transcriptional 
activation of the Pentose Phosphate Pathway (PPP) (Duvel, Yecies et al. 2010; Ben-Sahra, 
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Howell et al. 2013; Robitaille, Christen et al. 2013) . mTORC1 upregulates protein synthesis 
through activation of S6K and inhibition of the eukaryotic translation initiation factor 4E-
Binding Protein (4E-BP) that stimulates cap-dependent mRNA translation and biogenesis of 
ribosomes (Kawasome, Papst et al. 1998; Wang, Li et al. 2001; Laplante and Sabatini 2012; 
Thoreen, Chantranupong et al. 2012; Chauvin, Koka et al. 2014). The anabolic functions of 
mTORC1 are summarized in a Figure I1. 
 
 
 
Figure I1. Anabolic functions of mTORC1. Adapted from (Howell, Ricoult et al. 2013) 
 
Alongside with promoting anabolic pathways, mTORC1 inhibits catabolic pathways in the 
presence of nutrients through suppression of macroautophagy. During macroautophagy 
(hereafter referred to as “autophagy”) cellular proteins and organelles are sequestered into 
double-membrane autophagosomes that subsequently fuse with lysosomes (autolysosomes), 
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where degradation occurs. Nutrient deprivation results in decreased mTORC1 activity that in 
turn leads to induction of autophagy.  The catabolites derived from autophagy maintain the 
cell in a metabolically active state ensuring important cellular functions needed for cell 
survival (Shintani and Klionsky 2004; Rabinowitz and White 2010; Lamb, Yoshimori et al. 
2013). Interestingly, autophagy was shown to re-activate mTORC1 after prolonged nutrient 
starvation, thus providing a regulatory loop between catabolic and anabolic activities of 
mTORC1 (see Figure I2) (Yu, McPhee et al. 2010).  
 
 
 
Figure I2. Coordination between anabolic and catabolic branches of mTORC1 pathway
Introduction. Control of mTORC1 activity by nutrients 
21 
 
7.2. Control of mTORC1 activity by nutrients 
How nutrients, in particular amino acids, regulate mTORC1 activity has remained a 
conundrum for more than a decade. After publication of first reports on amino acid-sensitive 
regulation of mTORC1 effectors (Blommaart, Luiken et al. 1995; Hara, Yonezawa et al. 
1998), several distinct proteins have been suggested to be important. For instance, type III 
phosphatidylinositol-3-OH kinase VPS34, Mitogen-activated protein kinase kinase kinase 
kinase 3 (MAP4K3) and Phospholipase D1 were added to the list of potential regulators of 
nutrient-dependent  activity of mTORC1 (Nobukuni, Joaquin et al. 2005; Findlay, Yan et al. 
2007; Xu, Salloum et al. 2011). The model, which dominates now, largely relies on regulation 
of subcellular localisation of active mTORC1. Based on newly developed antibodies against 
mTORC1 members, the laboratory of David Sabatini found that amino acids induced 
translocation of mTORC1 to the membrane of lysosome (Sancak, Peterson et al. 2008; 
Sancak, Bar-Peled et al. 2010). The laboratories of Sabatini and Kun-Liang Guan revealed 
that this process is controlled by protein complexes which reside at lysosomal membranes, 
such as heterodimeric Rag GTPases (Rag A/B bound to Rag C/D) and  Ragulator (Kim, 
Goraksha-Hicks et al. 2008; Sancak, Peterson et al. 2008; Sancak, Bar-Peled et al. 2010) (see 
Figure I3). Amino acids activate Rag GTPases by promoting GTP loading of Rag A/B and 
GDP loading of Rag C/D. Activated Rags bind Raptor, one of the members of the mTORC1 
complex, recruiting mTORC1 to lysosomal membranes. The Ragulator and GATOR1 
complexes were identified as a guanine nucleotide exchange factor (GEF) and GTPase-
activating protein (GAP) for Rag A/B, respectively (Bar-Peled, Schweitzer et al. 2012; Bar-
Peled, Chantranupong et al. 2013), while Folliculin tumor suppressor (FLCN) was shown to 
serve as a GAP for Rag C/D (Tsun, Bar-Peled et al. 2013). In addition to the amino acid- 
dependent Rag-mTOR axis,  the Rag GTPases were recently found to be involved in 
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inhibition of mTORC1 by glucose deprivation, thus suggesting that inputs from different 
nutrients converge into lysosomal activation of mTORC1 (Efeyan, Zoncu et al. 2013).  
 
 
Figure I3. Rags and Ragulator recruit mTORC1 to lysosomes.  
Adopted from (Sancak, Bar-Peled et al. 2010) 
 
How is mTORC1 activated on lysosomal membranes? It was shown that lysosomal mTORC1 
is activated by another small GTPase, called Rheb, which also resides at lysosomal membrane 
(Sancak, Peterson et al. 2008; Sancak, Bar-Peled et al. 2010). Rheb is a crucial activator of 
mTORC1 and it had been extensively studied together with its inhibitor TSC complex (that 
serves as a GAP for Rheb) as a key player in local and systemic nutrient-dependent mTORC1 
regulation (Garami, Zwartkruis et al. 2003; Inoki, Li et al. 2003; Saucedo, Gao et al. 2003; 
Stocker, Radimerski et al. 2003; Dibble, Elis et al. 2012; Demetriades, Doumpas et al. 2014; 
Menon, Dibble et al. 2014). 
Why does the lysosome serve as a compartment where mTORC1 activation occurs? A 
possible explanation is that mTORC1 senses nutrients derived from lysosomes. In line with 
this assumption, the lysosomal amino acid transporter PAT1 was shown to interact with the 
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Rag GTPases and is required for amino acid-dependent mTOR localisation. Additionally, the 
Rag-Ragulator complex interacts with the vacuolar H
+–adenosine triphosphatase (v-ATPase), 
thus linking amino acid sensing to the lysosomal lumen (Zoncu, Bar-Peled et al. 2011; 
Ogmundsdottir, Heublein et al. 2012). Interestingly, several non-lysosomal amino acid 
transporters were also shown to be essential for mTORC1 activation (Nicklin, Bergman et al. 
2009). It is also possible that certain amino acids specifically control mTORC1 activity 
upstream of Rags. For instance, leucine was shown to regulate mTORC1 through leucyl-
tRNA synthetase (LeuRS) (Han, Jeong et al. 2012); and glutamine, the most abundant amino 
acid in the blood, was found to induce Rag-dependent mTORC1 activation through its 
catabolite α-ketoglutarate (Duran, Oppliger et al. 2012).  
It is worth pointing out that other mechanisms besides the Rag-Ragulator axis might be 
involved in nutrient-dependent mTORC1 translocation to lysosomes. For instance, glucose 
and glutamine were shown to control the functional assembly and lysosomal localisation of 
mTORC1 in parallel to Rags via a multiprotein complex TTT-RUVBL1/2 (Kim, Hoffman et 
al. 2013). Another study identified VPS34 and Phospholipase D, as Rag-independent 
regulators of amino acid-dependent mTORC1 activation on the lysosomal membrane (Xu, 
Salloum et al. 2011; Yoon, Du et al. 2011). In addition, Oshiro et al. found that amino-acid 
mediated activation of mTORC1 did not depend on GTP-loading of Rags, thus suggesting 
Rag-independent mechanisms of mTORC1 activation (Oshiro, Rapley et al. 2014). That being 
said, it is important to note, that the Rag-mTORC1 axis is present in other model organisms, 
such as the fruit fly Drosophila melanogaster  and baker’s yeast Saccharomyces cerevisiae, 
representing an evolutionary conserved mechanism (Kim, Goraksha-Hicks et al. 2008; 
Sancak, Peterson et al. 2008; Binda, Peli-Gulli et al. 2009; Sancak, Bar-Peled et al. 2010; 
Gong, Li et al. 2011; Panchaud, Peli-Gulli et al. 2013; Panchaud, Peli-Gulli et al. 2013). 
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7.3. Autophagy pathway: mechanisms and regulation 
Shortage of nutrients results in upregulation of catabolic pathways. Autophagy (from the 
Greek “self-eating”) is one of the most studied catabolic processes in eukaryotic cells. 
Autophagy was discovered by electron microscopy in 1950-s (Novikoff, Beaufay et al. 1956; 
Clark 1957; Novikoff 1959) and this morphological approach has remained a predominant 
method to study this process for several decades (Eskelinen, Reggiori et al. 2011). On the 
morphological level, autophagy starts by forming a double membrane phagophore (or 
isolation membrane) that expands and engulfs cytoplasmic components, and finally forms a 
closed compartment – the autophagosome. Autophagosomes fuse with other autophagosomes 
and subsequently – with endosomes and lysosomes, to form so called “autolysosomes”. In 
autolysosomes numerous catabolic enzymes degrade the cytoplasmic components that were 
captured by autophagosomes (Lamb, Yoshimori et al. 2013). 
Numerous studies have established autophagy as a major cellular pathway involved in 
overcoming stress conditions, such as nutrient deprivation (Kuma and Mizushima 2010). 
However, nutrient-repleted cells also display a certain level of autophagy – so called “basal 
autophagy”. Basal autophagy eliminates damaged or excess proteins and organelles, thus 
fulfilling housekeeping functions. Basal autophagy is important for maintenance of various 
organs such as brain, liver and heart (Komatsu, Waguri et al. 2005; Hara, Nakamura et al. 
2006; Nakai, Yamaguchi et al. 2007; Kuma and Mizushima 2010; Mizushima and Komatsu 
2011).
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7.3.1 Molecular mechanisms of autophagy 
The molecular mechanisms of autophagy remained unknown till 1990-s, when extensive 
genetic studies in S. cerevisiae, performed by the laboratories of Yoshinori Ohsumi, Michael 
Thumm and Daniel Klionsky, resulted in the identification of the large (more than 30 
members) ATG family of genes involved in this pathway (Takeshige, Baba et al. 1992; 
Tsukada and Ohsumi 1993; Thumm, Egner et al. 1994; Harding, Hefner-Gravink et al. 1996; 
Schlumpberger, Schaeffeler et al. 1997). The rapid progress in understanding autophagic 
mechanisms in yeast had greatly facilitated similar studies in mammalian models, as the 
majority of ATG proteins are conserved in mammals (Mizushima, Sugita et al. 1998; Kabeya, 
Mizushima et al. 2000; Mizushima, Yamamoto et al. 2004). Several functional modules of 
proteins have been found in the autophagic machinery, including:  
a) The ULK/Atg1 complex, in which the Serine/threonine-protein kinase ULK1 plays a key 
role in the induction of autophagy under nutrient starvation conditions; 
b)  The type III phosphatidylinositol kinase VPS34/Beclin 1 complex that is crucial in early 
stages of autophagy; 
c) Two ubiquitin-like conjugation systems Atg12–Atg5 and microtubule-associated protein 1 
light chain 3 (LC3), which are responsible for the formation of autophagosomes. 
The schematic overview of these key players in autophagy is shown on Figure I4. 
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Figure I4. An overview of the autophagic machinery 
The ULK/Atg1 complex 
Unc-51 like kinase-1 (ULK1), a mammalian homolog of yeast ATG1 was identified as a key 
autophagy regulator in a siRNA screen, performed by the laboratory of Sharon Tooze. They 
found that siRNA-mediated knockdown of ULK1 was sufficient to block starvation-induced 
autophagy in HEK293 cells (Chan, Kir et al. 2007). Subsequent work revealed other members 
of the ULK complex, including ATG13, ATG101 and RB1CC1 (also known as FIP200) 
(Ganley, Lam du et al. 2009; Hosokawa, Hara et al. 2009; Jung, Jun et al. 2009). Both ATG13 
and RB1CC1 are phosphorylated by ULK1 (Chan, Kir et al. 2007). Interestingly, mammals 
have another homolog of ATG1 – ULK2; and ULK1 and ULK2 are functionally redundant in 
mice (McAlpine, Williamson et al. 2013). The ULK complex is required for initial stages of 
starvation-induced autophagy. The exact molecular mechanisms remain, however, obscure. 
One interesting link between ULK and other autophagy players was recently found by the 
laboratory of Kun-Liang Guan. They identified Beclin 1, an important regulator of autophagy 
(see below), as a substrate of ULK1, and found that phosphorylation of Beclin 1 by ULK1 is 
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necessary for full induction of autophagy in response to amino acid deprivation (Russell, Tian 
et al. 2013).   
 
The VPS34/Beclin 1 complex 
The type III phosphatidylinositol-3-OH kinase (PI(3)K) complex consists of  several 
members, including  VPS34, VPS15 (p150), Beclin 1, Rubicon and ATG14 (Kihara, Kabeya 
et al. 2001; Zhong, Wang et al. 2009). Upon activation, the PI(3)K complex produces a pool 
of phosphatidylinositol-3-phosphate (PtdIns(3)P), which recruits its effectors such as WIPI2 
(Atg18) to promote autophagosome formation and maturation (Polson, de Lartigue et al. 
2010). 
 
In spite of the identification of numerous molecular players involved in the initial stages of 
autophagy, their exact role and place of action is not yet fully understood.  Almost every 
membrane compartment in eukaryotic cell has been suggested as a source for isolation 
membranes: endoplasmic reticulum, plasma and nuclear membranes, mitochondria and Golgi 
apparatus (Yamamoto, Masaki et al. 1990; English, Chemali et al. 2009; Hayashi-Nishino, 
Fujita et al. 2009; Yla-Anttila, Vihinen et al. 2009; Hailey, Rambold et al. 2010; Ravikumar, 
Moreau et al. 2010; Hamasaki, Furuta et al. 2013). According to the current view, activated 
ULK and VPS34/Beclin 1 complexes drive the formation and nucleation of isolation 
membranes from endoplasmic reticulum. Subsequently, the ubiquitin-like conjugation 
systems is recruited to the expanding isolation membranes (Lamb, Yoshimori et al. 2013). 
 
The ubiquitin-like conjugation systems in autophagy 
Two ubiquitin-like conjugation systems, the ATG5-ATG12 and the light chain-3 
(LC3)/ATG8 are crucial for the expansion of isolation membranes and formation of 
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autophagosomes. These systems employ ubiquitin-like (Ubl) proteins (ATG12 and LC3 
respectively) and the Ubl conjugation machinery to recruit LC3 to both, isolation membranes 
and autophagosomes. 
In the Atg5-Atg12 system the E1-like activating enzyme ATG7 and the E2-like conjugating 
enzyme ATG10 catalyze the covalent binding of ubiquitin-like protein Atg12 to an internal 
Lysine residue in Atg5 (Mizushima, Sugita et al. 1998; Mizushima, Yamamoto et al. 2001) . 
Subsequently, Atg5-Atg12 bind to Atg16 (Apg16L), and altogether they are recruited to 
isolation membranes (Mizushima, Kuma et al. 2003; Fujita, Itoh et al. 2008).  
The second Ubl conjugation system mediates the conjugation of Ubl LC3 (homologous to 
Atg8 in S. cerevisiae) to phosphatidylethanolamine.  First, the cysteine protease ATG4 
cleaves carboxy-terminal residues from LC3 to reveal a carboxy-terminal Glycine, which is 
subsequently activated by ATG7 (Ichimura, Kirisako et al. 2000; Kirisako, Ichimura et al. 
2000). Then, the E2-like conjugating enzyme ATG3 and the Atg12–Atg5–Atg16 complex, 
that serves as an E3-like enzyme, covalently bind cleaved LC3 (termed LC3-I) through its 
carboxy-terminal glycine to phosphatidylethanolamine (PE) in isolation membranes to form 
LC3-II (Ichimura, Kirisako et al. 2000; Fujita, Itoh et al. 2008).  
Why is lipidated LC3 required for initial stages of autophagy? This important question is not 
fully resolved yet. Currently, it is believed that LC3 promotes expansion and completion of 
autophagosomes, due to its ability to interact with and recruit other proteins to growing 
autophagosomes, thus defining the cytoplasmic substrates of autophagy and ensuring proper 
functioning of autophagosomes (Mizushima, Yoshimori et al. 2011; Lamb, Yoshimori et al. 
2013). It is also important to note that LC3 is not the only homolog of yeast ATG8 in 
mammals. The mammalian genome contains at least 8 orthologs of ATG8, that belong to 
three subfamilies: LC3, γ-aminobutyric acid (GABA) receptor-associated protein 
(GABARAP) and Golgi-associated ATPase enhancer of 16 kDa (GATE16, also known as 
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GABARAPL2). While the role of LC3, in particular LC3B, in autophagy is best studied to 
date, GABARAP/GATE16 members may also be important in distinct steps of autophagy 
(Kabeya, Mizushima et al. 2004; Weidberg, Shvets et al. 2010; Shpilka, Weidberg et al. 
2011). 
A substantial number of autophagic players do not belong to the three major groups 
mentioned above. For instance, the transmembrane protein ATG9 is required for initial steps 
of autophagy.  In particular, the trafficking of ATG9 from juxtanuclear position in the Golgi 
to peripheral endosomes upon induction of autophagy is important for formation of 
autophagosomes (Young, Chan et al. 2006). Another important example led to an answer to a 
long-running question related to mechanisms underlying the latest steps of autophagy. A 
recent study from the laboratory of Noboru Mizushima identified syntaxin 17, located on the 
autophagosomal membrane, as a SNARE protein that interacts with SNAP-29 and the 
endosomal/lysosomal SNARE VAMP8 to mediate fusion of autophagosome to lysosomes 
(Itakura, Kishi-Itakura et al. 2012). 
7.3.2. Regulation of autophagy by mTORC1 
As it was mentioned above, mTORC1 is a major suppressor of autophagy.  The best known 
functional link between mTORC1 and autophagy is inhibitory phosphorylation of the ULK 
complex by mTORC1. It was shown that active mTORC1 directly binds to ULK1 through 
Raptor and phosphorylates ULK1/ULK2 as well as ATG13 (Ganley, Lam du et al. 2009; 
Hosokawa, Hara et al. 2009; Jung, Jun et al. 2009; Kim, Kundu et al. 2011; Shang, Chen et al. 
2011). Interestingly, mTORC1-mediated phosphorylation of the ULK complex does not 
disturb its assembly, which is the case in yeast. Therefore, it is possible that phosphorylation 
of ULK1 by mTORC1 exerts its inhibitory functions by changing ULK localisation, 
separating it from its autophagic targets (Wong, Puente et al. 2013).  
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Besides ULK, several other proteins involved in autophagy are controlled by mTORC1. 
Death-associated protein 1 (DAP1) which was identified as a suppressor of autophagy was 
shown to be a target of mTORC1, but the exact function of DAP1 in autophagy remains 
elusive (Koren, Reem et al. 2010). The autophagic protein WIPI2 was found as a potential 
substrate of mTORC1 in a large phosphoproteome screen (Hsu, Kang et al. 2011). In addition, 
a recent study from the laboratory of Francesco Cecconi unveiled a new link between 
mTORC1 and ULK. They found that Beclin 1-interacting protein AMBRA1 promotes 
ubiquitination of ULK complex on Lysine 63 by E3-ligase TRAF6, that results in enhanced 
stability and activity of the ULK complex. They showed that mTORC1 inhibits AMBRA1, 
thus impairing ubiquitination of ULK complex (Nazio, Strappazzon et al. 2013). 
Several signalling networks involved in the regulation of autophagy converge into mTORC1. 
For example, AMP-activated kinase (AMPK) serves as a low energy sensor that counteracts 
mTORC1. AMPK was shown to inhibit mTORC1 by phosphorylating Raptor (Gwinn, 
Shackelford et al. 2008). In addition, AMPK phosphorylates and activates ULK1, which is 
prevented by mTORC1-mediated ULK1 phosphorylation (Kim, Kundu et al. 2011). 
Conclusively, it is important to note that our current knowledge of autophagy is far from 
being complete. The overview of basic mechanisms shown here does not stand as a dogma. 
Importantly, certain autophagic pathways do not rely on the VPS34/Beclin 1 complex 
(Scarlatti, Maffei et al. 2008), on ULK (Cheong, Lindsten et al. 2011) or even on LC3 
(Nishida, Arakawa et al. 2009) and mTORC1 (Williams, Sarkar et al. 2008).
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7.4. Pancreatic β cells sense nutrient availability to control whole 
body metabolism 
On the organismal level, the control of metabolism is achieved through the coordinated action 
of hormones produced by the endocrine system. In mammals, nutrient availability is sensed 
by pancreatic β cells that produce and secrete insulin – the central anabolic hormone. In a fed 
state, glucose together with other nutrients (such as amino acids) derived from the food, 
induce secretion of insulin by β cells. Secreted insulin increases glucose uptake in the body 
and promotes anabolic processes in tissues. The mechanisms of β cell function, in particular, 
insulin production and secretion have been a subject of extensive studies for many decades, as 
the failure of β cells results in a severe  metabolic disorder – Diabetes mellitus (Ashcroft and 
Rorsman 2012).  
Insulin is synthesized as a precursor preproinsulin on the ribosomes of the Rough 
Endoplasmic Reticulum (RER), and is cleaved to proinsulin during its translocation into the 
lumen of RER. Subsequently, proinsulin molecules pass through RER and Golgi to the Trans-
Golgi Network (TGN) to be packed inside of the special vesicles, so-called insulin Secretory 
Granules (SGs). SGs serve as a compartment where maturation of proinsulin to insulin occurs 
through coordinated activity of endopeptidases. Exocytosis of SGs upon stimulation results in 
insulin release (Goodge and Hutton 2000; Steiner 2011). The main steps of insulin 
biosynthesis are shown on a Figure I5. 
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Figure I5. An overview of the insulin biosynthesis. RER: Rough Endoplasmic Reticulum. 
PM: plasma membrane. Schematic representations of human proinsulin and insulin molecules 
are shown on the right 
 
While the core machinery underlying insulin biosynthesis and secretion is relatively well 
studied, the signalling cascades involved in its regulation are less well understood. A series of 
studies, performed in our lab unveiled a novel signalling axis that controls secretion of 
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insulin. We identified Protein Kinase D1 (PKD1) as a key regulator of early steps of SGs 
biogenesis. PKD1 phosphorylates BAR domain-containing protein Arfaptin-1 at Serine 132, 
which is required for timely scission of SGs at the TGN (Gehart, Goginashvili et al. 2012). 
Importantly, upregulation of PKD1 activity in vivo results in a marked increase in insulin 
secretion and protects β cells in a model of diabetes (Sumara, Formentini et al. 2009). 
How do nutrients promote insulin release? According to the most accepted model, metabolic 
activity in β cells drives secretion of insulin (Prentki, Matschinsky et al. 2013; Rorsman and 
Braun 2013). The activation of metabolism due to uptake of nutrients leads to the raise of 
cellular ATP/ADP ratio, which results in the closure of ATP-sensitive potassium channels. 
Due to the latter event, rapid depolarisation of cell membrane occurs, thus promoting opening 
of calcium channels and subsequent calcium influx. Subsequently, increased cellular calcium 
triggers exocytosis of SGs (Prentki, Matschinsky et al. 2013). In spite of the fact that some of 
the distal steps of insulin secretion events had been recently debated (Szollosi, Nenquin et al. 
2007; Szollosi, Nenquin et al. 2007; Ravier, Nenquin et al. 2009), the consensus is reached on 
the tight link between β cell metabolism and secretion of insulin (Ashcroft and Rorsman 
2012; Prentki, Matschinsky et al. 2013; Rorsman and Braun 2013).  
While enormous number of studies concentrated on the response of β cells to nutrient uptake, 
surprisingly little is known about the β cells’ behaviour during fasting, when secretion of 
insulin is kept at a very low level. Moreover, the role of autophagy in the adaptation of β cells 
to shortage of nutrients is not entirely clear. Although experiments in starved pancreatic islets 
and β cell lines suggested the involvement of autophagy in the nutrient starvation response, 
especially after long-term starvation, studies performed in mice did not reveal an increase in 
autophagy under starvation conditions (Ebato, Uchida et al. 2008; Fujitani, Ueno et al. 2010). 
Only prolonged starvation of mice for 24 hours induced autophagy in β cells (Fujimoto, 
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Hanson et al. 2009).  Conclusively, the cellular mechanism underlying the nutrient starvation 
response in pancreatic β cells currently remains elusive and is the subject of my thesis.  
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8. Materials and Methods 
The text and figures shown in chapters ‘Materials and Methods’ and ‘Results and Discussion’ 
have been partially taken from the following manuscript: 
 Goginashvili A., Erbs E., Kessler P., Pasquier A., Schieber N., Cinque L., Krupina K., 
Morvan J., Sumara I., Schwab Y., Settembre C., Ricci R. PKD links Golgi to nutrient 
starvation response in pancreatic β cells. Science (in revision). 
 
8.1. Materials 
Reagents were obtained from the following sources: HRP-labeled anti-mouse and anti-rabbit 
secondary antibodies from IGBMC; antibodies to phospho-S757 ULK1, ULK1, phosphoT389 
S6K1, S6K1, mTOR from Cell Signaling Technology; antibody to LC3B (2G6) from 
nanoTools; antibody to Lamp1 (Ly1C6) from  Cayman Chemical; antibody to Proinsulin (C-
Peptide I) from Serotec; antibody to  Giantin from Enzo Life Sciences; antibody to Green 
Fluorescent Protein from Fisher Scientific; antibody to PKD1 (c-20) from Santa Cruz; Gö 
6976, type V Collagenase solution, Histopaque 1119, Pepstatin A, E64D, amino acids, 
Bafilomycin A1, puromycin, antibodies against GAPDH and insulin, non-silencing small 
hairpin RNAs, small hairpin RNAs against PKD1 from Sigma Aldrich;  Vectashield from 
Vector Laboratories;  Mowiol from Calbiochem; cOmplete Protease Inhibitor Cocktail 
Tablets from Roche; Rapamycin, Torin 1 and CID755673 from Tocris Biosciences; 4’,6-
diamidino-2-phenylindole (DAPI), Image-iT® FX signal enhancer and Alexa -488, -568 and 
647 conjugated secondary antibodies from Life Technologies; DyLight 405-conjugated 
secondary antibody from  Jackson ImmunoResearch Laboratories; Alexa-488 conjugated 
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secondary antibody pGolgi-CFP (Addgene: 14873, deposited by Alexandra Newton, 
University of California at San Diego), ptfLC3 (Addgene: 21074, deposited by Tamotsu 
Yoshimori, Osaka University), pEGFP-LC3 (Addgene: 21073, deposited by Tamotsu 
Yoshimori), Lamp1-RFP (Addgene: 1817, deposited by Walther Mothes, Yale University) 
were obtained from Addgene. G-PKDrep-live (Eisler, Fuchs et al. 2012) was kindly provided 
by Angelika Hausser (University of Stuttgart).  Phogrin-GFP (Pouli, Emmanouilidou et al. 
1998) was kindly provided by Guy Rutter (Imperial College London). An antibody against 
Phogrin was a generous gift from John Hutton (University of Colorado).  
 
8.2. Mice 
p38δ-/- mice were described previously (Sumara, Formentini et al. 2009). GFP-LC3 transgenic 
mice were generated by Noboru Mizushima (Mizushima, Yamamoto et al. 2004)  and 
distributed by the RIKEN Bio-Resource Center (Japan). Maintenance and animal 
experimentation were in accordance with the Committee on Animal Care at Azienda 
Ospedaliera “Antonio Cardarelli”, Italy or the veterinarian services, Strasbourg, France in 
compliance with the European legislation on care and use of laboratory animals. 
 
8.3. Cell lines and transfections 
INS1 cells were maintained in RPMI 1640 supplemented with 10%  FCS, 10 mM Hepes, 1 
mM PyrNa. HEK293 and INS1 cells were transfected by using Amaxa Nucleofector (Lonza) 
according to the manufacturer's protocol. PKD1 was knocked down by lentiviral transduction 
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of small hairpin constructs in pLKO.1 puro (Sigma Aldrich) against PKD1. The cells were 
selected by addition of 0.5 ug/ml Puromycin (Sigma Aldrich).  
 
8.4. Nutrient deprivation  
For nutrient deprivation almost confluent INS1 cells, HEK293 cells  or intact primary islets 
were incubated in Krebs-Ringer Bicarbonate Buffer (KRB) (136 mM NaCl, 4.7 mM KCl, 1.2 
mM MgS04, 1 mM CaCl2, 1.2 mM KH2PO4, 5 mM NaHCO3, 10 mM HEPES (pH 7.4)) , 
supplemented with 0.5% BSA (designated as “no Glc/FCS”) or with 5.5 mM or 11 mM 
glucose (“no AA/FCS”) and compared to full media (“GC”). For an experiment shown in Fig 
4H,  intact primary islets were incubated in KRB, supplemented with 0.5% BSA and 2.8 mM 
glucose. Inhibitors of lysosomal proteases  Pepstatin A (10 µg/ml) and E64D (10 µg/ml) were 
used in experiments, shown in Fig R2C and R2D.  
To address nutrient starvation response in β cells in vivo (Fig R1E) mice were pre-fasted for 
24 h, then fed  for 2 h (9AM–11AM) (designated as “Fed”) and either sacrificed or re-fasted 
for 4h (designated as “Fasted”) prior sacrifice.   
  
8.5. Immunofluorescence 
INS1 cells were plated on 9-15 mm glass coverslips (Menzel-Glaser) in 24-well tissue culture 
plates and allowed to grow for 24 hours. In the end of experiment the cells were washed once 
with PBS and fixed for 20 minutes with 4% paraformaldehyde (PFA) in PBS at room 
temperature. The coverslips were rinsed twice with PBS and permeabilized with 0.1% Triton 
X-100 in PBS for 5 minutes. After rinsing three times with PBS, the coverslips were blocked 
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by Image-iT FX signal enhancer (Life Technologies), rinsed once with PBS and incubated for 
30 minutes in blocking buffer (3% BSA in PBS). Coverslips were subsequently incubated 
with primary antibodies in blocking buffer for 1 hour at room temperature or overnight at 
4°C, rinsed three times with PBS  and incubated with secondary antibodies, diluted in 
blocking buffer, for one hour at room temperature in the dark. After incubation coverslips 
were rinsed three times with PBS (with DAPI added in the 2
nd
 wash step, where indicated) 
and mounted on glass slides using Vectashield (Vector Laboratories) or Mowiol (Calbiochem) 
and imaged with a 100X or 63X objective using epifluorescence microscope or confocal 
microscope Leica Spinning Disk Andor/Yokogawa.   
 
8.6. Histochemistry 
Pancreata were fixed by intracardiac perfusion with PFA 4% in PBS. Tissues were postfixed 
overnight at 4°C in the same solution, cryoprotected in 30% sucrose in PBS solution, 
embedded in Cryomatrix (Thermo scientific) and kept at -80° C.  Pancreas sections were cut 
with a cryostat (CM3050, LEICA) and mounted on Superfrost Ultra Plus slides (Menzel-
Glaser). 10 µm cryosections were incubated for 2 hours at room temperature  in the  blocking 
solution (PBS/ 5% Normal Goat Serum /0.3% TritonX100), then left overnight  at 4°C, in a 
wet chamber,  with a mouse monoclonal  primary antibody  raised against Insulin ( I2018, 
Sigma Aldrich) and a rabbit polyclonal primary  antibody raised against (GFP,A-6455, Fisher 
scientific) diluted in the blocking  solution. After 3 washes in PBS, the sections were blocked 
for 15 min at room temperature in the blocking solution and incubated for 2 hours at room 
temperature, in wet chamber, with an Alexa-568 conjugated Goat Anti Mouse secondary 
antibody (A11031, Molecular Probes) and an Alexa-488 conjugated Goat Anti Rabbit 
secondary antibody (A11034, Fisher scientific) diluted in the blocking solution. 
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After 3 washes in PBS, 1 wash in H2O and 1 brief wash in ethanol 70%, the slides were dried 
and mounted in Mowiol (Calbiochem) containing DAPI (0.5μM). Images were taken using 
confocal microscope Leica Spinning Disk Andor/Yokogawa. 
 
8.7. Isolation of pancreatic islets 
Mice were anesthetized by a mix of 20% ketamine-10% xylasine. Islets were isolated by 
perifusion of 5ml of type V Collagenase (Sigma Aldrich) solution and separation through a 
Histopaque 1119 (Sigma Aldrich) gradient. Islets were kept in RPMI 1640 supplemented with 
10%FCS, 10mM Hepes, 1mM PyrNa and penicillin/streptomycin. 
 
8.8. Transmission electron microscopy (TEM) 
For TEM, cells and primary islets were first fixed in 0.05% malachite green, 2.5% 
glutaraldehyde, 0.1 M sodium cacodylate buffer, postfixed in 0.8% K3Fe(CN)6,  1.0% OsO 
K3Fe(CN)6 and stained with 1% tannic acid and 0,5% uranyl acetate. The samples were then 
dehydrated in graded ethanol solutions and embedded in Epon (Ladd Research Industries). 
Ultrathin sections (50-60 nm) were examined under a Philips CM12 80 kV electron 
microscope equipped with an ORIUS SC1000 CCD camera. 
Quantitative analyses of autophagic compartments of INS-1 cells and primary islets have been 
assessed by TEM as described (Yla-Anttila, Vihinen et al. 2009). Briefly, the areas of 
cytoplasm and Golgi were evaluated by stereological approach using x5600 magnification 
with ImageJ-based open-source Fiji software package. The numbers of autophagic 
compartments were quantified using x15000 magnification. Data from 3 independent 
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experiments were expressed as mean ± SEM. The numbers of granule-containing lysosomes 
(GCLs) in Golgi area were counted for 30 cells from 3 independent experiments using x19500 
magnification. The data were expressed as mean ± SEM. All quantitative analyses relied on 
systematic uniform random sampling.  
 
8.9. Correlative Light and Electron Microscopy (CLEM) 
CLEM was performed as described (Lenormand, Spiegelhalter et al. 2013). In brief, INS1 
cells were cultured on laser micro-patterned Aclar supports. In the end of experiment the cells 
were fixed in PFA 4%, Glutaraldehyde 0,5% in sodium cacodylate 0,1M for 20 minutes at 
room temperature, followed by incubation in  sodium cacodylate 0,1M. Cells of interest were 
selected, precisely located and imaged by fluorescence confocal microscopy using Leica 
Spinning Disk Andor/Yokogawa microscope. The samples were then processed exactly as for 
TEM.  
 
8.10. Ratiometric measurements and analysis 
INS1 cells, transiently transfected with G-PKDrep-live were plated on glass bottom Petri 
dishes (ASAHI GLASS Co, Iwaki) and allowed to grow for 24 hours. Cells were incubated in 
Phenol Red-free RPMI 1640 supplemented with 10%FCS, 10mM Hepes, 1mM PyrNa and 
penicillin and streptomycin 12 hours prior imaging.  
Ratiometric measurements were performed on a Leica TCS SP8 AOBS inverted confocal 
microscope, with a Leica HC PL APO CS2 63x/1.2 water immersion objective. Fluorescence 
excitation was achieved using an Argon Laser (458 nm) and two Leica HyD detectors were 
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used to simultaneously record the emission of the donor (CFP) and acceptor (YFP) signals 
between 467-497 nm and 535-565 nm respectively. A “cube & box” system from Life 
Imaging Services was used to keep both cells and microscope under 37°C and the Leica 
Adaptive Focus Control (AFC) was engaged to maintain the focus during the time-lapse 
imaging. Multi-position imaging was performed to record cells automatically, providing a 
time-resolution of 1 image / 30 s per cell. 
YFP/CFP ratio from 30 cells from 3 independent experiments was calculated cell by cell and 
time by time using a macro developed on ImageJ-based open-source Fiji software package. 
Ratios were normalized and represented on figure 4F as mean ± s.e.m. 
 
8.11. Metabolic labeling with [35S] methionine 
Proinsulin biosynthesis and conversion of proinsulin to insulin were analyzed by (pro)insulin 
immunoprecipitation of [35S] methionine-radiolabeled INS-1 lysates as described 
(Wicksteed, Herbert et al. 2001).  Briefly, to address proinsulin biosynthesis INS 1 cells were 
incubated in KRB with 2.8 mM glucose for 1 hour, followed by incubation in KRB either 
with 2.8 mM or 22 mM glucose. The last 20 minutes of incubation was carried out in the 
presence of 250 µCi/ml [35S]-methionine. Then cells were collected, washed, lysed in IP 
Buffer (50 mM Tris (pH 7.5), 50 mM NaCl, 0.5% Triton X-100, 0.5% NP40 substitute, 5 mM 
EGTA, 5 mM EDTA, 20 mM NaF, 25 mM beta-glycerophosphate, 1 mM PMSF, 0.1 mM 
NaVO3, 1x complete protease inhibitor (Roche)) and subsequently immunoprecipitated for 
(pro)insulin with Anti-Insulin antibody (I8510, Sigma Aldrich). Immunoprecipitated 35S-
labeled (pro)insulin was then subjected to SDS-PAGE and visualized by phosphoimager.  
In pulse-chase experiments, INS 1 cells were incubated in KRB with 25 mM glucose for 1 
hour, the last 30 minutes of incubation were carried out in the presence of 250 µCi/ml [35S]-
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methionine (pulse). After pulse, cells were washed and then chased for 0, 3 or 6 hours in KRB 
with 5.5 mM glucose.  At each chase time point, cells were collected, washed, lysed in IP 
Buffer and subsequently immunoprecipitated for (pro)insulin with Anti-Insulin antibody 
(I8510, Sigma). Immunoprecipitated [35S]-labeled (pro)insulin was then subjected to SDS-
PAGE and visualized by phosphoimager. 
 
8.12. Insulin secretion 
Insulin secretion was performed as previously described (Sumara, Formentini et al. 2009). 
Briefly, INS-1 cells were incubated for 30 min in KRB supplemented with 0.5% BSA, and 2.8 
mM glucose. Subsequently, INS-1 cells were incubated for 1 hourr in the same buffer in 
presence of Rapamycin (100 nM) or DMSO. After 1 hourr the supernatant was collected and 
the remaining cells were lysed in IP Buffer. The insulin secretion in the supernatants was 
measured using an Ultra Sensitive Mouse Insulin ELISA Kit (ALPCO Diagnostics). Data 
were normalized to non-treated control cells. 
 
8.13. Cell lysis  
Cells were rinsed once with ice-cold PBS and lysed in ice-cold lysis buffer (50 mM Tris (pH 
7.5), 50 mM NaCl, 0.5% Triton X-100, 0.5% NP40 substitute, 5 mM EGTA, 5 mM EDTA, 
20 mM NaF, 25 mM beta-glycerophosphate, 1 mM PMSF, 0.1 mM NaVO3, 1x complete 
protease inhibitor (Roche)). The soluble fractions of cell lysates were isolated by 
centrifugation at 12800 rpm for 10 minutes. 
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8.14. Molecular cloning 
Cloning of cytoplasmic tail (amino acids 625-1004) of Phogrin into pGex-4T1 in frame with 
GST was performed by PCR amplification of this region in Phogrin-GFP, which introduced 
restriction sites for restriction enzymes EcoRI and SalI, used for following restriction and 
ligation. Primers used for cloning were: 5’CCCGAATTCGCCTACTGCCTCCGC3’ 
(forward) and 5’CCGTCGACCTACTGGGGAAGGGC-C3’ (reverse). Restriction and 
ligation were performed according to standard procedures using restriction enzymes and 
ligase from New England Biolabs and Fermentas. 
  
8.15. Generation of recombinant proteins 
pGex-4T1 vector was used for expression of GST-tagged proteins in BL21DE3 strain. At log 
phase of growth (OD600 0.5), protein expression was induced by addition of isopropyl-β-D-
thiogalactopyranosid (IPTG) (0.4 mM) at 25 °C for 4 hours. Then, cells were resuspended in 
15 ml of NETN buffer containing  complete protease inhibitor (Roche) and lyzed by addition 
of Lysozyme (100 ug/ml), followed by 30 minutes of incubation on ice and subsequent 
sonication. The lysates were cleared by centrifugation (12000g, 15 minutes, 4°C). Next, 500 
µl of glutathione (GSH)-bound beads were added to the supernatant, followed by mixing by 
rotation for 2 hours at 4°C. The beads were collected and washed 4 times with NETN. The 
GST-tagged proteins were eluted twice with reduced Glutathione (Sigma Aldrich) (15 mM in 
Tris (pH 9)) for 15 minutes. Eluates were dialysed and stored at -80°C in PBS substituted 
with 20% Glycerol. 
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8.16. In-vitro kinase assay 
Recombinant GST-tagged PhogrinCyto and hArfaptin-1 were incubated with recombinant 
PKD1 (GenWay) in Kinase Buffer (20 mM MgCl, 25 mM Hepes pH 7.6, 1 mM DTT) 
supplemented with 20 mM ATP and 5 µCi [gamma-32P] ATP for 30 minutes at 30°C in the 
presence of absence of 50 µM Gö6976 (Sigma Aldrich). Next, proteins were separated by 
SDS-PAGE and blotted on PVDF membranes. Autoradiography was visualized by 
phosphoimager. 
 
8.17. Mammalian lentiviral shRNAs 
shPKD1_1 
CCGGGAAACACGAAACTTGTTATTGCTCGAGCAATAACAAGTTTCGTGTTTCTTTTTTG 
shPKD1_2 
CCGGCCCACGCTCTCTTTGTTCATTCTCGAGAATGAACAAAGAGAGCGTGGGTTTTT 
 
8.18. Statistical analyses  
The statistical significance of the differences between two groups was investigated by 
unpaired t test or by Mann - Whitney U-test. For comparison of more than two groups one-
way ANOVA followed by Tukey HSD test was used. The statistical analysis was performed 
using GraphPad Prism software (GraphPad Software Inc.). 
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9. Results and Discussion 
Proper nutrient sensing is crucial for multicellular organisms. In mammals upon feeding, the 
pancreatic β cells mainly sense increasing glucose levels and secrete insulin that acts to 
induce anabolic pathways in different organs. Inversely, the β cells decrease insulin secretion 
to suppress these anabolic reactions upon low glucose levels during fasting (Rorsman and 
Braun 2013). As known for many eukaryotic cells, nutrient deprivation is expected to induce 
autophagy. During autophagy, cellular components are sequestered into double-membrane 
autophagosomes, which subsequently fuse with lysosomes (autolysosomes), where 
degradation occurs. Resulting catabolites maintain cells metabolically active, ensuring cell 
survival (Shintani and Klionsky 2004; Rabinowitz and White 2010; Lamb, Yoshimori et al. 
2013). However, the role of autophagy in the nutrient starvation response in pancreatic β cells 
remains elusive (Ebato, Uchida et al. 2008; Fujimoto, Hanson et al. 2009; Fujitani, Ueno et al. 
2010) and is addressed in my study. 
 
9.1. Nutrient depletion suppresses autophagy in β cells 
Firstly, I wanted to address the role of autophagy in the nutrient starvation response of β cells. 
To this aim, I used LC3B localisation as the readout of autophagy. As mentioned above, 
induction of autophagy is marked by incorporation of LC3B into membranes of 
autophagosomes that appear as punctate structures (Tanida, Ueno et al. 2004). INS1 cells (β 
cell line derived from insulinoma of rats) that transiently expressed LC3B tagged with GFP 
(LC3B-GFP) contained 35.62 ± 2.87 (hereafter, shown as mean ± s. e. m.) LC3B-GFP puncta 
under nutrient-rich conditions, indicating basal autophagy. Unexpectedly, INS1 cells deprived 
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of serum and amino acids (AA) for 2 or 6 hours contained 14.5 ± 1.14 and 18.56 ± 1.51 
LC3B-GFP puncta, respectively. Similarly, depletion of INS1 cells from serum and glucose 
(Glc) for 2 or 6 hours drastically decreased LC3B-GFP puncta to 8.08 ± 1.01 and 13.08 ± 
1.51, respectively (Fig. R1A). Deprivation from serum alone did not change the amount of 
LC3B-GFP puncta (Supplementary fig. R1). In strong contrast and as previously reported 
(Kabeya, Mizushima et al. 2000), starved human embryonic kidney 293 (HEK-293) cells 
displayed markedly increased LC3B-GFP puncta as compared to non-starved cells 
(Supplementary fig. R2).  
Reduction in LC3B-GFP puncta may be explained by two scenarios. First, it is possible that 
autophagy is decreased upon nutrient starvation. Alternatively, decreased number of LC3B-
GFP puncta at a particular time point may indicate high autophagy with rapid lysosomal 
disposal of LC3B-GFP, resulting in disappearance of the GFP signal. To distinguish between 
these two possibilities, I measured autophagic flux with the help of RFP-GFP tandem 
fluorescence-tagged LC3 (ptfLC3). In ptfLC3 expressing cells, the GFP tag is acid-sensitive 
and the RFP tag is acid-insensitive, allowing for discrimination between yellow fluorescent 
autophagosomes and red fluorescent autolysosomes (Kimura, Noda et al. 2007). Time-lapse 
fluorescent microscopy of INS1 cells transfected with ptf-LC3 deprived from serum and AA 
or Glc revealed rapid reduction in the number of RFP-GFP and no increase in RFP-only 
puncta (Fig. R1B and Supplementary fig. R3).  To confirm the autophagic origin of RFP-GFP 
and RFP-only puncta, I performed Correlative Light and Electron Microscopy (CLEM). 
CLEM corroborated reduced numbers of autophagosomes and unchanged numbers of 
autolysosomes in AA/serum-depleted INS1 as compared to non-starved cells (Fig. R1C). 
Quantitative EM (QEM) confirmed this observation in β cells of AA/serum-deprived murine 
primary islets, revealing 12.43 ± 1.73 and 3.6 ± 0.6 autophagic compartments 
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(autophagosomes and autolysosomes) per 100 µm
2 
under nutrient-rich conditions and upon 
AA/serum deprivation, respectively. (Supplementary fig. R4).  
To measure endogenous autophagic flux, I used Bafilomycin A1 (Baf A1) that blocks 
autolysosomal degradation of LC3B (Yamamoto, Tagawa et al. 1998). Treatment with Baf A1 
led to a decreased accumulation of lipidated autophagosomal LC3B (LC3B-II) in AA/serum-
starved as compared to non-starved INS1 cells, indicating decreased autophagic flux upon AA 
deprivation (Fig. R1D). Observed changes of autophagy were confirmed in vivo comparing β 
cells in pancreatic islets derived from fed and  fasted LC3B-GFP expressing mice 
(Mizushima, Yamamoto et al. 2004). β cells of fed and fasted mice contained 33.08 ± 2.20 
and 21.53 ± 1.75 LC3B-GFP puncta per 1600 µm
2
, respectively (Fig. R1E). Collectively, the 
obtained data suggest that autophagy is not a major mechanism to overcome nutrient 
deprivation in β cells. 
 
9.2. Nutrient depletion induces SINGD in β cells 
The findings shown above strongly suggest that  cells utilize a distinct mechanism to adapt 
to changes in nutrient availability. Besides autophagy, selective degradation of secretory 
granules (SGs) by their direct fusion with the lysosomes in the process called “crinophagy”, 
could be involved in β cells response to starvation (Smith and Farquhar 1966; Sandberg and 
Borg 2006). To analyze crinophagy, I assessed cellular localization of lysosomal Lamp1 and 
SG protein Phogrin. Phogrin- and Lamp1-positive puncta in INS1 cells increased from 14.6 ± 
1.18 under growing conditions to 37.6 ± 1.98 upon AA and serum withdrawal for 2 hours 
(Fig. 2A). Lamp1 and Phogrin preferentially co-localized in proximity to the Golgi (Fig. 
R2A). QEM of AA/serum starved INS1 cells corroborated this finding, revealing abundant 
lysosomes containing electron-dense SGs in proximity of the Golgi (Supplementary fig. R5). 
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CLEM confirmed that the latter structures corresponded to puncta of Lamp1 and Phogrin 
colocalization (Fig. R2B). In addition, treatment of AA/serum-deprived cells with lysosomal 
protease inhibitors increased Lamp1 and Phogrin co-localization in comparison with non-
starved cells (Fig R2C), confirming lysosomal degradation of SGs. 
SGs are generated at the trans-Golgi network (TGN). I thus wondered whether nascent 
granules are specifically targeted to lysosomes. Readily formed SGs contain proinsulin, which 
is subsequently converted into insulin (Steiner, Cunningham et al. 1967). 6 hour depletion 
from AA and serum led to an almost complete loss of proinsulin (Fig. R2D). Decrease of 
proinsulin was partially restored by lysosomal protease inhibitors (Fig R2D) suggesting that 
nutrient deprivation leads to lysosomal degradation of de novo synthesized SGs in pancreatic 
β cells. I confirmed aforementioned findings ex vivo, by performing QEM of nutrient-
deprived primary murine islets. QEM revealed abundant lysosomes that contained electron-
dense SGs in the Golgi areas of AA/serum–starved islets (Fig. R2E and quantification in 
Supplementary fig. R6). Overall, these data suggest that β cells mainly employ Starvation-
Induced Nascent Granule Degradation (SINGD) instead of autophagy to counteract shortage 
of nutrients. 
 
9.3. SINGD suppresses autophagy in an mTOR-dependent manner 
Lysosomal AAs derived from degraded proteins induce translocation of mammalian (or 
mechanistic) Target Of Rapamycin Complex 1 (mTORC1) to lysosomal membranes (Sancak, 
Peterson et al. 2008; Zoncu, Bar-Peled et al. 2011), mTORC1 activation (Sancak, Peterson et 
al. 2008; Zoncu, Bar-Peled et al. 2011) and subsequent suppression of autophagy (Yu, 
McPhee et al. 2010; Betz and Hall 2013; Kim, Buel et al. 2013). Do lysosomes involved in 
SINGD suppress autophagy through mTORC1? Strikingly, mTOR inhibitors rapamycin and 
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torin 1 increased the number of LC3B-GFP puncta in AA/serum-depleted INS1 cells to 24.25 
± 1.79 and 25.4 ± 2.32, respectively as compared to 11.5 ± 0.97 LC3B-GFP puncta in non-
inhibited AA/serum-depleted INS1 cells (Fig. R3A). This indicates that mTORC1 activity is 
required for suppression of autophagy upon starvation. Moreover, depletion of AA and serum 
from INS1 cells resulted in translocation of mTOR to Phogrin/Lamp1-positive puncta close to 
the Golgi area (Fig. R3B). mTORC1 was shown to suppress starvation-induced autophagy 
through inhibitory phosphorylation of  Unc-51-like kinase 1 (ULK1) on Serine 757 (ULK1-
S757). Thus, starvation is expected to decrease ULK1-S757 phosphorylation (Kim, Kundu et 
al. 2011). Western blotting revealed that ULK1-S757 phosphorylation levels remained high in 
starved as compared to non-starved INS1 cells (Fig. R3C). Importantly, phosphorylation of 
ULK1-S757 was markedly decreased when mTORC1 was inhibited by rapamycin (Fig. R3C). 
Interestingly, while under nutrient-rich conditions S757-ULK1 phosphorylation appeared as 
discrete fluorescent dots throughout the cytoplasm, AA/serum deprivation led to the 
formation of large bright S757-ULK1 puncta that co-localized with both Lamp1 and Phogrin 
close to the Golgi (Fig. R3D). Collectively, these data suggest that mTORC1-mediated 
ULK1-S757 phosphorylation in the SINGD compartment is important for suppression of 
autophagy. Levels of ULK1-S757 phosphorylation did not increase under starving as 
compared to growing conditions, suggesting that observed basal autophagy in non-starved 
cells is largely independent of ULK1-S757 phosphorylation. Phosphorylation of the mTORC1 
substrate S6K1 on threonine 389 (T389), involved in regulation of protein translation 
(Pearson, Dennis et al. 1995), almost completely disappeared during starvation (Fig. R3C). 
This is in line with a previous report showing that S6K1 phosphorylation requires higher 
mTOR activity than ULK1 phosphorylation (Kang, Pacold et al. 2013). Altogether, these data 
suggest that nutrient depletion leads to induction of SINGD that locally activates mTOR to 
suppress autophagy. 
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9.4. PKD1 is a key player in SINGD 
9.4.1. Inactivation of PKD1 is sufficient to trigger SINGD 
How is SINGD controlled? Degradation of nascent SGs in vicinity of the Golgi is likely to 
rely on molecular mechanisms involved in SG biogenesis. We and others identified Protein 
Kinase D1 as a key regulator of early steps of insulin SG biogenesis at the TGN (Sumara, 
Formentini et al. 2009; Gehart, Goginashvili et al. 2012; Cruz-Garcia, Ortega-Bellido et al. 
2013). Thus, PKD1 inactivation could have an effect on the turnover of de novo formed SGs. 
Indeed, treatment of INS1 cells with the PKD inhibitor CID 755673 (Sharlow, Giridhar et al. 
2008) markedly decreased the amount of proinsulin (Fig. R4A). This decrease in proinsulin 
content could be due to decreased biosynthesis of proinsulin or because the β cells cannot 
properly store it. To distinguish between these possibilities, I tested the rates of proinsulin 
biosynthesis in INS1 cells stably expressing shRNA against PKD1 or control non-silencing 
shRNA.  The biosynthesis of proinsulin was unchanged in the absence of PKD1 as compared 
to control (Supplementary fig. R7 and R8). However, accumulation of newly formed insulin 
was markedly decreased in PKD1 knockdown cells, indicating enhanced degradation of de 
novo synthesized insulin (Supplementary fig. R9). QEM analysis of cells lacking PKD1 
revealed abundant lysosomes that contained SGs in the Golgi area (Fig. R4B and 
Supplementary fig. R10). Would inactivation of PKD1 lead to mTOR-dependent suppression 
of autophagy, as SINGD does? Strikingly, mTOR largely co-localized with lysosomal Lamp1 
in cells depleted of PKD1 (Fig. R4C). Moreover, mTOR-mediated ULK1-S757 
phosphorylation was markedly increased (Fig. R4D). As in SINGD, autophagic flux was 
considerably suppressed upon PKD1 knockdown (Fig. R4E).  
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9.4.2. Nutrients control activity of PKD1 
If SINGD is controlled by PKD1, PKD1 activity in the Golgi is likely to be regulated by 
nutrients.  
Catalytically inactive mutants of PKD1 were used to address the localization of this kinase in 
response to different stimuli (Liljedahl, Maeda et al. 2001; Baron and Malhotra 2002; 
Hausser, Link et al. 2002). I found that GFP-tagged catalytically inactive K612W mutant of 
PKD1 (PKD1-K612W-GFP) was localised to Golgi and plasma membrane under growing 
conditions in INS1 cells. Interestingly, deprivation of the INS1 cells expressing PKD1-
K612W from AA/serum or Glc/serum for 30 min resulted in a markedly decreased number of 
cells with the Golgi-localised PKD1-K612W (Supplementary fig. R11). 
To assess activity of PKD1 in the TGN, I used a TGN-localized Fluorescence Resonance 
Energy Transfer (FRET) reporter (G-PKDrep-live) (Eisler, Fuchs et al. 2012) and performed 
time-lapse FRET measurements upon nutrient deprivation in INS1 cells. The FRET signal 
was rapidly and markedly decreased during deprivation of AA/serum or Glc/serum as 
compared to growing conditions, indicating inactivation of PKD1 in the TGN upon nutrient 
withdrawal (Fig. R4F). 
9.4.3. Inactivation of PKD1 is necessary for SINGD 
It was previously found in the laboratory that loss of the MAPK p38δ leads to enhanced 
PKD1 activity in β cells (Sumara, Formentini et al. 2009). To test if PKD1 controls SINGD, I 
performed QEM of β cells of fasted islets isolated from p38δ knockout (p38δ-/-) and control 
(p38δ+/+) mice. p38δ+/+ β cells displayed abundant lysosomes containing electron-dense SGs, 
which were markedly decreased in p38δ-/- cells indicating reduced SINGD. In contrast, 
autophagic compartments were dramatically increased in starved p38δ-/- β cells showing that 
Results and Discussion. Nutrient starvation response in β cells – a link to β cell function 
52 
 
SINGD-dependent suppression of autophagy was diminished (Fig. R4G and quantification in 
Supplementary fig. R12). Our data thus suggest that PKD1 is a major regulator of SINGD in β 
cells. 
 
9.5. Nutrient starvation response in β cells – a link to β cell function 
The aforementioned findings strongly suggest that pancreatic β cells employ a very distinct 
cellular mechanism to overcome nutrient deprivation. In particular, starved β cells induce 
lysosomal degradation of nascent secretory insulin granules in the vicinity of the Golgi. 
Starvation-Induced Nascent Granule Degradation (SINGD) is controlled by Protein Kinase 1 
(PKD1), a key player in Secretory Granule (SG) biogenesis. SINGD in turn triggers 
lysosomal recruitment and activation of mechanistic Target Of Rapamycin (mTOR) that 
suppresses autophagy.  
Why do β cells employ such a distinct strategy to overcome nutrient deprivation? What is the 
physiological sense of this mechanism? The main systemic function of β cells is to control the 
whole body metabolism through secretion of insulin. Therefore, it is possible that response of 
β cells to nutrient deprivation is related to the regulation of metabolism.  Under fasting 
conditions, when nutrient supply drops, insulin release is maintained at a low level. Unwanted 
insulin secretion from β cells during fasting results in a further decrease in Glc  level in the 
blood, thus exacerbating fasting conditions (Gremlich, Nolan et al. 2005). Starvation-induced 
autophagy partially restores metabolic activity of the cell, by providing metabolites derived 
from degraded organelles and proteins. Since the metabolic activity in β cells is a major 
trigger of insulin secretion, induction of autophagy may thus lead to the increased secretion of 
insulin. Importantly, several metabolites generated through autophagy are known to promote 
insulin release (Prentki, Matschinsky et al. 2013). Since secreted insulin lowers blood Glc, 
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unwanted insulin secretion may in turn lead to a further increase of fasting-induced autophagy 
in starved β cell, resulting in further enhanced insulin secretion and thus providing a 
deleterious cycle leading to exhaustion of β cells and drop in blood Glc level. Based on these 
assumptions, it is possible to expect that observed suppression of autophagy in β cells during 
fasting contributes to fasting-induced suppression of insulin secretion.  As shown in figure 
R3A, rapamycin treatment derepressed autophagy in starved INS1 cells. Therefore, to test the 
role of autophagy in fasting-induced suppression of insulin secretion, I treated INS1 cells with 
rapamycin at non-stimulatory Glc concentrations, corresponding to physiologic fasting Glc 
levels, and measured insulin release. Keeping autophagy high in β cells at non-stimulatory 
Glc levels precluded suppression of insulin secretion (Fig. R4H). This finding is in line with 
the previous report from our laboratory, in which it was shown that p38δ-/- mice, characterised 
by decreased SINGD and increased autophagy in their β cells, displayed higher fasting insulin 
release than control mice (Sumara, Formentini et al. 2009). In contrast, studies of mice, 
completely lacking autophagy in their β cells due to β-cell-specific ablation of the key 
autophagy gene ATG7, showed decreased fasting insulin level as compared to control mice 
(Ebato, Uchida et al. 2008; Jung, Chung et al. 2008). Therefore, suppression of autophagy in 
starved β cells may represent a strategy to avoid unwanted insulin secretion during fasting.
SINGD, the alternative strategy to overcome nutrient deprivation, does also provide 
metabolites due to lysosomal degradation of SGs components. Why then activation of SINGD 
does not result in unwanted secretion of insulin? Interestingly, the newly formed SGs were 
shown to be preferentially released from β cells (Gold, Gishizky et al. 1982; Halban 1982; 
Michael, Xiong et al. 2007; Hou, Mogami et al. 2012). Therefore, targeting nascent SGs to 
lysosomes in SINGD provides nutrients that are needed to overcome fasting conditions and at 
the same time limits insulin secretion by depleting the “secretable” pool of SGs and by 
suppressing autophagy. Importantly, long-term fasting is expected to deplete β cells of 
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nascent SGs in the course of SINGD, which would in turn lead to the derepression of 
autophagy at some point, as no more “secretable” SGs would be targeted to the lysosomes. 
This  explains upregulation of autophagy upon prolonged fasting for 24 and 48 hours, 
observed in primary β cells and β cell lines (Fujimoto, Hanson et al. 2009).  
Altogether, rapid inactivation of PKD1 upon nutrient starvation results in SINGD, localized 
activation of mTOR and suppression of autophagy. On the other hand, PKD1 activity is 
required for proper SG biogenesis and subsequent insulin secretion. Thus, PKD1-dependent 
balance between SINGD and secretion contributes to maintenance of β cell function 
(Supplementary fig. R13). 
 
9.6. A potential role of the SINGD-autophagy axis in Diabetes 
Failure of pancreatic β cells is a hallmark of  a relentless metabolic disorder – Diabetes 
mellitus, an increasingly prevailing disease which is currently affecting more than 350 million 
people worldwide (Danaei, Finucane et al. 2011; Whiting, Guariguata et al. 2011; Ashcroft 
and Rorsman 2012; Chen, Magliano et al. 2012). Therefore, identification of pathways, 
responsible for maintenance of β cell function is very important for understanding the 
mechanisms of this disease and for development of effective treatment strategies. Several 
studies revealed autophagy as a protective pathway against β cell failure. An increase in 
autophagy was found in β cells derived from diabetic patients and rodent models of Diabetes 
(Li, Zhang et al. 2006; Ebato, Uchida et al. 2008; Masini, Bugliani et al. 2009). In addition, 
upregulation of autophagy was shown to be protective against ER stress-induced Diabetes 
(Bachar-Wikstrom, Wikstrom et al. 2013). Furthermore, loss of autophagy results in 
compromised β cell function and leads to decreased β cell survival (Ebato, Uchida et al. 2008; 
Jung, Chung et al. 2008; Quan, Hur et al. 2012). It is important to note that p38δ-/- mice, 
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which displayed decreased SINGD and increased autophagy (Fig. R4G), were found to be 
protected against β cell failure in a PKD1-dependent manner in a murine Diabetes model 
(Sumara, Formentini et al. 2009). Taking this into account, it would be very interesting to 
explore the potential role of the PKD1-dependent SINGD-autophagy axis in the context of 
Diabetes.  
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9.7. Outlook and perspectives 
The mechanism of the fasting response identified in my study implies PKD1-dependent 
lysosomal degradation of nascent SGs, which in turn leads to suppression of autophagy via 
local activation of mTOR. These findings provoke several new questions, which will be very 
interesting to address in the future, such as identifying the molecular mechanisms of SINGD, 
exploring SINGD in vivo, unravelling the dynamics of PKD1-SINGD-autophagy pathway in 
the context of disease (diabetes) and investigating the specificity of this pathway in a cellular 
and evolutionary context. 
 9.7.1. Identification of molecular mechanisms of SINGD 
In the nearest future, it will be important to identify molecular mechanisms downstream of 
PKD1, determining the destination of SGs either to secretory or to degradative pathways. As I 
have shown that kinase activity of PKD1 controls the fate of SGs, it is particularly important 
to identify the target(s) of PKD1 involved in these processes. Several strategies can be 
proposed to address this question: 
1. An unbiased approach, based on the comparison of phosphoproteome of INS1 cells, stably 
expressing a wild type, constitutive active (S744E/S748E) and dominant negative PKD1 
(K612W or K618N) will provide us a list of potential targets of PKD1 in pancreatic β cells. 
Phosphorylation by PKD1 is expected to protect SGs from SINGD.  Therefore, for a 
secondary screen, I suggest to perform a genetic inactivation of identified hits (via 
knockdown or knockout), using stability of SGs as a readout, which can be easily assessed by 
measuring the levels of SGs markers, such as (Pro)insulin and Phogrin. As a next step, I will 
address the stability of SGs in INS1 cells expressing identified proteins, harbouring mutations 
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in the PKD1-dependent phosphorylation sites. For the confirmed hits I plan to explore their 
cellular localisation and phosphorylation by PKD1 under nutrient-rich and nutrient-poor 
conditions.  
2. As a phosphoproteomic approach has certain limitations, for example, it is difficult to 
identify targets of PKD1 that are expressed at low levels, I will conduct another screen, 
similar to a secondary screen suggested above, including the libraries of genes, involved in 
the control of cellular traffic, secretion and degradation processes. Moreover, it would be very 
interesting to perform the same screen in PKD1 knockdown cells to find the genes responsible 
for targeting SGs to the lysosomes. A combination of these approaches will shed light on the 
molecular mechanisms of SINGD and on the origin of SINGD compartments. 
3. Exploring the documented targets of PKD1 in pancreatic β cells may provide additional 
insights on the mechanisms of SINGD. For instance, BAR domain-containing protein 
Arfaptin 1 was recently identified in our laboratory as a target of PKD1 in pancreatic β cells. 
Phosphorylation of Arfaptin 1 by PKD1 is required for correct scission of SGs at the TGN 
(Gehart, Goginashvili et al. 2012). Expression of non-phosphorylatable mutant of Arfaptin 1 
results in incomplete scission of SGs and therefore leads to accumulation of non-detached 
SGs in Golgi area. However, these SGs are not targeted to the lysosomes, thus indicating the 
involvement of other target(s) of PKD1 in SINGD. This being said, it will still be important to 
explore the alterations of Arfaptin1 phosphorylation upon nutrient deprivation and to address 
its potential cooperation with other target(s) of PKD1, involved in the control of SINGD. 
A recently published phosphoproteomic study of INS1 cells has identified several potential 
targets of PKD1 (Han, Moon et al. 2012). Among them, transmembrane SG protein Phogrin, 
used as a SG marker in my studies, is of particular interest, as it was shown to function as 
phosphatidylinositol phosphatase, involved in the control of SGs trafficking and exocytosis 
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(Caromile, Oganesian et al. 2010). Intriguingly, deletion of Phogrin, as well as deletion of its 
close homologue IA-2 in mice results in a drastic decrease in number of SGs due to markedly 
increased lysosomal targeting and degradation of SGs (Cai, Hirai et al. 2011). Based on these 
observations, it is possible to assume that Phogrin is involved in the regulation of SINGD 
through PKD1. My preliminary data suggest that PKD1 phosphorylates the cytoplasmic tail of 
Phogrin at Ser 641, 681 and 687 in vitro (Supplementary fig. R14 – R16). Importantly, 
phosphorylation of Ser 687 in Phogrin was identified in vivo in the phosphoproteomic study 
mentioned above (Han, Moon et al. 2012). As a next step, I plan to explore the 
phosphorylation of Phogrin by PKD1 in INS1 cells comparing phosphorylation of Phogrin in 
INS1 cells, stably expressing a wild type, constitutive active and dominant negative PKD1. In 
addition, I aim at addressing PKD1-dependent phosphorylation of Phogrin under nutrient-rich 
and nutrient-poor conditions. If Phogrin is downstream of PKD1 in the regulation of SINGD, 
the disruption of PKD1-dependent phosphorylation of Phogrin will result in SINGD. 
Therefore, I plan to address the SGs dynamics in INS1 cells, expressing the 
unphosphorylatable mutants of Phogrin, using as a starting point S687A, S641A and S681A 
Phogrin mutants. If these experiments provide evidence for Phogrin to be a target of PKD1 in 
SINGD, the mechanisms of PKD1-dependent Phogrin activity will be explored, including the 
possible alterations of its phosphatidylinositol phosphatase activity in presence/absence of 
active PKD1, changes in its localisation and interactions with other proteins, involved in SGs 
trafficking. 
The identification of target(s) of PKD1 in SINGD will provide us with the possibility to 
genetically dissect SINGD events and autophagy events and therefore to better understand the 
interaction between these pathways.   Moreover, establishing the specific markers of SINGD 
will be very useful for biochemical characterisation of SINGD compartments.  
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9.7.2. PKD1-SINGD-autophagy pathway in healthy and disease state in 
vivo. 
In my study, I characterised SINGD in the cellular models and in β cells of isolated primary 
islets. In the future, I plan to explore SINGD in vivo, for example, in fed and fasted mice. To 
do so, a combination of morphological and biochemical approaches can be suggested. First, I 
aim at visualiazing SINGD in β cells of fed and fasted mice with the help of 
immunohistochemistry, using markers of SGs, such as Pro(insulin) and lysosomes, such as 
Lamp1 or Lamp2. This approach will be corroborated with ultrastructural studies of these 
cells by electron microscopy, followed by immunogold labelling with SGs and lysosomal 
markers. 
The findings shown in my study suggest the presence of a relatively high level of basal 
autophagy in non-fasted β cells. Taken together with the reported importance of basal 
autophagy in maintenance of β cells and in secretion of insulin (Ebato, Uchida et al. 2008; 
Jung, Chung et al. 2008), these observations suggest a functional significance of basal 
autophagy in β cells. One explanation for this phenomenon takes into account the well-
established house-keeping role of autophagy, which relies on the clearance of damaged 
organelles and misfolded proteins: the highly specialized secretory machines, such as β cells, 
constantly face a danger of high ER stress and accumulation of misfolded proteins upon high 
secretory demand, and therefore autophagy might be used to protect the cells from the 
negative consequences of secretory burden (Bachar-Wikstrom, Wikstrom et al. 2013; Bachar-
Wikstrom, Wikstrom et al. 2013). From another hand, aforementioned studies, together with 
my work, suggest a correlation between autophagy and secretion of insulin, thus raising an 
interesting possibility of a potential link between these pathways. Insulin secretion is driven 
by a high metabolic activity in β cells that relies on a high supply of nutrients. Do nutrients 
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derived from lysosomes participate in insulin secretion even in fed state?  To address this 
question, it will be needed to study nutrient-induced insulin secretion while challenging 
autophagic and lysosomal activity, with the help of chemical compounds targeting cellular 
degradative pathways and by using genetic approaches (for example, by deleting lysosome-
specific amino acid transporters). 
Another important problem is the potential relevance of the PKD1-SINGD-autophagy 
pathway in the context of disease: Does the evolutionary adaptation of β cells to fasting play a 
role in failure of β cells in diabetes?  To address this question, I plan to explore the identified 
mechanism in pre-diabetic/diabetic β cells. As a complementary approach, I would like to 
investigate a potential role of SINGD and/or suppression of autophagy in diabetes, by 
studying β cells from pre-diabetic/diabetic mice perturbing PKD1 activity. These changes will 
be induced acutely by PKD-specific inhibitors or genetically, with the help of p38δ-/- and β 
cell-specific PKD1 knockout mice or mice expressing constitutively active PKD1. As studies 
of autophagy-deficient and p38δ-/-  mice suggest a beneficial role of autophagy in diabetes, it 
would be interesting to develop tools, specifically triggering autophagy in β cells, for 
example, by chemical coupling of an autophagy-inducing drug, such as modified tat-beclin1 
peptide (Shoji-Kawata, Sumpter et al. 2013), to  the agonist of β cell-specific surface receptor. 
9.7.3. Specificity of SINGD/autophagy in the cellular and evolutionary 
context. 
Is the identified mechanism restricted to β cells? May it be relevant for other cell types, such 
as other secretory cells and/or cells involved in nutrient sensing? One good candidate cell type 
in which this should be tested is the pancreatic α cells, which secretes glucagon upon low Glc 
and insulin levels. It will be intriguing to test the levels of autophagy and SINGD in these 
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cells upon fasting and feeding conditions. Therefore, I plan to address levels of autophagy in 
α cells of fed and fasted LC3B-GFP expressing mice, with the approach shown in Fig. R1E, 
using glucagon as an α-cell marker. Furthermore, I will explore SINGD in these cells, using 
glucagon as SGs marker and Lamp1 or Lamp2 as a marker for lysosomes. Besides α cells, 
other classical cellular secretory models, which will be interesting to investigate in future in 
the context of the PKD1-SINGD-autophagy pathway, include Adrenocorticotropic Hormone 
(ACTH)-secreting Att-20 cells, catecholamines-secreting PC12 cells and Immunoglobulin-
secreting plasma cells. With the help of genetic approaches, it will be a fascinating 
opportunity to expand these findings into a broader cellular and evolutionary context, by 
exploring PKD1-SINGD-autophagy pathway in a tissue-specific manner in simpler model 
organisms, like C. elegans or D. melanogaster. For example, it will be interesting to study 
these processes in secretory cells or neurons in these organisms. Addressing these questions 
will put the findings presented here in a broader context in cell biology and evolution. 
 
Results and Discussion. Main figures 
 
62 
 
9.8. Main figures 
 
 
 
 
Figure R1. Nutrient depletion suppresses autophagy in β cells. (A) Immunofluorescence 
(IF) of LC3B-GFP puncta (white arrows) in INS1 cells under growing conditions (GC), 
without amino acids and fetal calf serum (no AA/FCS) or glucose (no Glc/FCS) for 2 and 6 
hours. Quantification of LC3B-GFP puncta per cell (mean ± s. e. m.). **P<0.01. (B) Live 
Fluorescence Microscopy of ptfLC3 puncta (white arrows) in INS1 cells. Pictures were 
captured at indicated time points after AA/FCS withdrawal. Merged, GFP and RFP signals are 
shown separately. (C) CLEM of ptfLC3 expressing INS1 cells under GC and no AA/FCS for 
2 hours. EM, corresponding fluorescent and merged pictures are shown. Regions of interest 
(ROI) are indicated with labelled dashed squares. Yellow and black arrows indicate 
autophagosomes and autolysosomes, respectively. (D) Western blot of LC3B using lysates of 
INS1 cells treated with BafA1, 10 nM under GC and no AA/FCS for indicated time points. 
GAPDH was used as a loading control. (E) IF of LC3B-GFP puncta (white arrows) and 
insulin (red) in β cells in islets of fed and fasted LC3B-GFP expressing mice. The nucleus 
was stained with DAPI. Quantification of LC3B-GFP puncta per 1600 μm2(mean ± s. e. m.). 
**P<0.01. 
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Figure R2. Nutrient depletion induces SINGD in β cells. (A) Immunofluorescence (IF) of 
Phogrin and Lamp1 in INS1 cells under growing conditions (GC) or without amino acids and 
fetal calf serum (no AA/FCS) for 2 hours. Regions of interest (ROI) are indicated with dashed 
squares. White arrows indicate co-localization of Phogrin with Lamp1. A Golgi marker 
(pGolgi-CFP) was used. Quantification of co-localization of Phogrin and Lamp1 per cell 
(mean ± s. e. m.). **P<0.01. (B) CLEM of INS1 cells co-expressing Phogrin-GFP and 
Lamp1-RFP under GC and no AA/FCS for 2 hours. EM, corresponding fluorescent and 
merged pictures are shown. Regions of interest (ROI) are indicated with dashed squares. 
White arrows indicate co-localization of Phogrin-GFP with Lamp1-RFP. Yellow arrows 
indicate lysosomes correlated to co-localized Phogrin-GFP and Lamp1-RFP.  (C) IF of 
Phogrin and Lamp1 in INS1 cells treated with lysosomal inhibitors under GC and no AA/FCS 
for 2 hours. A Golgi marker (pGolgi-CFP) was used. (D) Western blot of proinsulin using 
lysates of INS1 cells treated or not with lysosomal inhibitors (LI) under GC and no AA/FCS 
for 6 hours. GAPDH was used as a loading control. (E) EM of Golgi areas in primary murine 
islets under GC and no AA/FCS for 2 hours. Yellow arrows indicate secretory granules-
containing lysosomes. Quantification in Supplementary fig. R6. 
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Figure R2 
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Figure R3. SINGD suppresses autophagy in an mTOR-dependent manner. (A) IF of 
LC3B-GFP puncta (white arrows) in INS1 cells under growing conditions (GC) or without 
amino acids and fetal calf serum (no AA/FCS) for 2 hours treated or not with rapamycin, 100 
nM or torin-1, 250 nM as indicated. Quantification of LC3B-GFP puncta per cell (mean ± s. 
e. m.). **P<0.01. (B) Immunofluorescence (IF) of mTOR in INS1 cells co-expressing 
Phogrin-GFP and Lamp1-RFP under GC and no AA/FCS for 2 hours. White arrows in 
regions of interest (ROI) highlighted with dashed squares indicate co-localization of Phogrin-
GFP with mTOR and Phogrin-GFP  with Lamp1-RFP. A Golgi marker (Giantin) was used. 
(C) Western blot of indicated proteins using lysates of INS1 cells treated or not with 
rapamycin, 100 nM under GC, no AA/FCS or without glucose/fetal calf serum (no Glc/FCS) 
for 2 hours. GAPDH was used as a loading control. (D) IF of phosphorylated ULK1 (S757-
ULK1) in INS1 cells co-expressing Phogrin-GFP and Lamp1-RFP under GC and no AA/FCS 
for 2 hours. ROI are indicated with dashed squares. White arrows in ROI indicate co-
localization of Phogrin-GFP with Lamp1-RFP and S757-ULK1. A Golgi marker (Giantin) 
was used.  
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Figure R3 
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Figure R4. PKD1 is both necessary and sufficient in SINGD. (A) Western blot of 
proinsulin using lysates of INS1 cells treated with CID755673 for indicated times. GAPDH 
was used as a loading control. (B) EM of Golgi areas in non-silenced and PKD1-depleted 
(shPKD1) INS1 cells. Yellow arrows indicate secretory granules-containing lysosomes 
(GCLs). Quantification in Supplementary fig. R9. (C) Immunofluorescence (IF) of mTOR 
and Lamp2 in non-silenced and PKD1-depleted (shPKD1) INS1 cells. White arrows indicate 
co-localization of mTOR with Lamp2. The nucleus was stained with DAPI. (D) Western blot 
of indicated proteins using lysates of non-silenced and PKD1-depleted (shPKD1) INS1 cells. 
GAPDH was used as a loading control. (E) Western blot of LC3B using lysates of non-
silenced and PKD1-depleted (shPKD1) INS1 cells treated with BafA1 at indicated 
concentrations for indicated times. GAPDH was used as a loading control. (F) Live-cell 
FRET assay in INS1 cells expressing G-PKDrep-live under growing culture (GC) conditions, 
without amino acids and fetal calf serum (no AA/FCS) or without glucose/FCS (no Glc/FCS). 
FRET was measured and expressed as normalized YFP-C/CFP ratios during a time course as 
indicated. (G) Upper panel: EM of Golgi areas of fasted β cells in primary islets of p38δ+/+ 
and p38δ-/- mice. Yellow arrows indicate secretory GCLs. Lower panel : EM of cytoplasm of 
fasted β cells in primary islets of p38δ+/+ and p38δ-/- mice. The yellow arrow indicates an 
autophagosome.  Quantifications in Supplementary fig. R10. (H) Insulin in supernatants of 
INS1 cells treated with non-stimulatory 2.8 mM Glc in presence of DMSO or rapamycin. 
Insulin concentrations are expressed as a percentage of DMSO control (mean ± s. e. m.).  
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9.9. Supplementary figures 
 
 
 
Supplementary Figure R1. Deprivation from serum alone did not affect LC3B-GFP 
puncta in starved INS1 cells. Quantification of LC3B-GFP puncta per cell in INS1 cells 
under growing conditions (GC) and without fetal calf serum (FCS) (mean ± s.e.m.). ns: not 
significant. 
 
 
 
Supplementary Figure R2. LC3B-GFP puncta increase in HEK293T cells upon nutrient 
starvation. Immunofluorescence (IF) of LC3B-GFP puncta (white arrows) in HEK293T cells 
under growing conditions (GC), without amino acids and fetal calf serum (no AA/FCS) or 
glucose/FCS (no Glc/FCS) for 2 and 6 hours. Quantification of LC3B-GFP puncta per cell 
(mean ± s.e.m.). *P<0.05,**P<0.01.   
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Supplementary Figure R3. Reduced autophagic flux in INS1 cells upon glucose (Glc) 
and fetal calf serum (FCS) withdrawal. Live Fluorescence Microscopy of ptfLC3 puncta 
(white arrows) in INS1 cells. Pictures were captured at indicated time points after Glc/FCS 
withdrawal. Merged, GFP and RFP signals are shown separately. 
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Supplementary Figure R4. Autophagic compartments (AC) decrease in β cells in 
primary murine islets upon AA/serum deprivation.  Electron microscopy of cytoplasm 
areas in β cells in primary murine islets under growing culture (GC) conditions or without AA 
and fetal calf serum (no AA/FCS) for 2 hours. Yellow arrows indicate ACs. Quantification of 
ACs per 100 μm2 (mean ± s.e.m.). ***P<0.001.   
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Supplementary Figure R5. Granule containing lysosomes (GCLs) increase in INS1 cells 
upon AA/serum deprivation.  Electron microscopy of Golgi areas in INS1 cells under 
growing culture (GC) conditions or without AA and fetal calf serum (no AA/FCS) for 2 
hours. Yellow arrows indicate GCLs. Quantification of GCLs (mean ± s.e.m.). **P<0.01.   
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Supplementary Figure R6. Granule containing lysosomes (GCLs) increase in β cells in 
primary murine islets upon AA/serum deprivation.  Quantification of GCLs in Golgi areas 
of β cells in primary murine islets under growing culture (GC) conditions or without AA and 
fetal calf serum (no AA/FCS) for 2 hours (mean ± s.e.m.). **P<0.01. 
 
 
 
 
Supplementary Figure R7. Short hairpin-mediated knockdown of PKD1 in INS1 cells. 
Western blot of PKD1 using lysates of INS1 cells stably expressing two different short 
hairpin RNAs against PKD1 (shPKD1-1 and shPKD1-2) or non-silencing shRNA. shPKD1-1 
is shown in further experiments. GAPDH is used as a loading control. 
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Supplementary Figure R8. PKD1 knockdown in INS1 cells does not alter proinsulin 
biosynthesis. Autoradiography of immunoprecipitated proinsulin using lysates of INS1 cells 
transfected with short hairpin RNA against PKD1 (shRNA) compared to cells transfected 
with non-silencing shRNA (NS) and incubated with indicated concentrations of glucose in 
presence of [35S]-methionine. Autoradiography of total input was used as a loading control. 
 
 
Supplementary Figure R9. PKD1 knockdown in INS1 cells decreases accumulation of 
newly formed insulin. Autoradiography of immunoprecipitated proinsulin/insulin using 
lysates of INS1 cells transfected with short hairpin RNA against PKD1 (shRNA) compared to 
cells transfected with non-silencing shRNA (NS) and incubated for 30 minutes with [35S]-
methionine (pulse) followed by chase for indicated times. Autoradiography of total input was 
used as a loading control. 
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Supplementary Figure R10. Increased granule containing lysosomes (GCLs) in INS1 
cells depleted of PKD1. Quantification of GCLs in INS1 cells transfected with short hairpin 
RNA against PKD1 (shRNA) compared to cells transfected with non-silencing shRNA (NS) 
(mean ± s.e.m.). ***P<0.001. Representative EM pictures are shown in Figure R4B. 
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Supplementary Figure R11. Nutrient deprivation decreases Golgi-specific localisation of 
PKD1-K612W-GFP in INS1 cells. Immunofluorescence (IF) of PKD1-K612W-GFP in INS1 
cells under growing conditions (GC), without amino acids and fetal calf serum (no AA/FCS) 
or glucose/FCS (no Glc/FCS) for 30 minutes. The nucleus was stained with DAPI. Percentage 
of INS1 cells with PKD1-K612W-GFP in Golgi (mean ± s.e.m.). **P<0.01, ***P<0.001.  
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Supplementary Figure R12. Granule containing lysosomes (GCLs) decrease and 
autophagic compartments (AC) increase in β cells in fasted primary murine islets of 
p38δ-/- mice  Quantification of GCLs in Golgi areas and of ACs in cytoplasm areas per 100 
μm2 of β cells in islets of mice as indicated (mean ± s.e.m.). **P<0.01. Representative EM 
pictures are shown in Figure R4G. 
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Supplementary Figure R13. Model highlighting links between SINGD, secretion and 
autophagy SG : secretory granule, PM : plasma membrane.  
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Supplementary Figure R14. PKD1 phosphorylates cytoplasmic tail of Phogrin 
(PhogrinCyto) in vitro.  Autoradiography of in vitro kinase assay using recombinant GST-
tagged cytoplasmic tail of Phogrin PhogrinCyto (69 kDa) after addition of recombinant PKD1 
without or with the PKD inhibitor Gö 6976. Wild-type human Arfaptin-1 (hArfaptin-1, 68 
kDa) and serine to alanine mutant Arfaptin-1 (hArfaptin-1 S132A) were used as positive and 
negative controls respectively. 
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Supplementary Figure R15. Phosphorylation of PhogrinCyto by PKD1 in vitro revealed 
by mass-spectrometry. Sequence coverage: 92.11 %. 3 phosphorylation sites were identified: 
S17, S57 and S63, corresponding to S641, S681 and S687 in full-length Phogrin respectively. 
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Supplementary Figure R16. Spectrum details of phosphorylation sites of PhogrinCyto.
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